Summarized by Masters of Longevity from Fight Aging!.
Reports on using existing transcriptomic data and network analyses to guide small-molecule screens that seek compounds shifting gene expression toward longevity-associated modules.
Key Takeaways
- The libraries are too large to screen everything (and even then the scope of the libraries is only a sampling of the space of the possible).
- Thus even unbiased screening starts with some hypothesis to cut down the number of molecules being screened to a tractable number for the time and budget at hand.
- Here, researchers discuss the use of existing transcriptomic data to guide drug screening approaches intended to uncover geroprotective compounds that adjust metabolism to modestly slow aging.
